Visiogen Gains $40M In Funding

Irvine-based Visiogen is reporting this morning that it has raised $40M in a financing round for its intraocular lens technology. The firm said the funding was led by Novartis Venture Fund, and also included investments from Technology Partners, Three Arch Partners, New Leaf Venture Partners, Prospect Venture Partners, CMEA Ventures and Foundation Medical Partners. Visiogen is developing a dual-optic accomodating intraocular lens. The firm last raised funding in 2007. More information »